Back to Agenda
How Standardized Protocol Data Plus AI Power Patient Centric Studies
Session Chair(s)
William Illis, MPH
Executive Director, Technology and Scientific Computing
Novartis , United States
Clinical trial start-up is often delayed by manual processes, fragmented systems, and inconsistent data. This workshop will explore how biopharmaceutical companies are using AI and interoperable data standards to enable patient centric study designs.
Learning Objective : Explain how AI and USDM (the CDISC digital protocol data standard) work together to streamline study design and protocol development; Discuss ways to achieve patient-centric design and reduced patient burdens using AI in conjunction with clinical standards; Examine how data standards enable interoperability and multi-stakeholder collaboration including with sites and patients.
Speaker(s)
Panelist
Nicholas Brooke, MBA
PFMD, Belgium
Executive Director, Patient Focused Medicines Development (PFMD)
Panelist
Vivian Dewoskin, MBA
Faro Health Inc., United States
Chief Commercial Officer
Panelist
Sahishnu Patel, PHD
Synterex, United States
Associate Director, AI Automation and R&D
Panelist
Prasanna Rao
Saama, United States
Chief Products and Innovation Officer
Have an account?